/C O R R E C T I O N — NeuroRx/

In the news release, NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19, issued 29-Mar-2021…

House begins voting on $1.9 trillion COVID relief bill

Vertex to begin Phase 1/2 trial of treatment for people with type 1 diabetes Shares of Vertex Pharmaceuticals Inc. were down 0.2% in trading on Wednesday after the company said it started an early-stage clinical trial for its experimental treatment for people with type 1 diabetes. It also said the therapy received a fast-track designation from the…

TSX falls as energy, materials drag

Article contentCanada’s main stock index fell for the first time in four sessions on Thursday, as weakness in energy and material stocks outweighed hopes of a large fiscal stimulus package...

Potential Priorities for Wall Street’s Next Top Cop

Five potential focuses for the next S.E.C. chairThe Biden administration is set to tap Gary Gensler, a former financial regulator and Goldman Sachs banker, as head of the Securities and...

Mydecine Innovations Group Shares Intellectual Property Update

Company files seven provisional patent applications with United States Patent and Trademark OfficeDENVER, Jan. 07, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA (“Mydecine” or...
Close
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close